Aurobindo Pharma shares up 0.01% as Sensex rises

Shares of Aurobindo Pharma Ltd. gained 0.01 per cent to Rs 463.1 in Wednesday's session as of 02:04PM (IST) even as the equity benchmark Sensex traded 405.17 points higher at 59367.29.

Earlier in the day, the stock witnessed a gap down start to the session. The stock quoted a 52-week high price of Rs 730.0 and a 52-week low of Rs 397.3 on NSE. Around 32563 shares changed hands on the counter till 02:04PM (IST).

The stock opened at Rs 457.05 and has touched an intraday high and low of Rs 465.0 and Rs 455.5 during the session so far. The counter quoted a price-to-earnings (PE) ratio of 13.57, earnings per share (EPS) of Rs 34.09 and price to book value (PB) of 1.59, while the return on equity (ROE) stood at Rs 10.77.

Promoter/ FII Holding
The promoters held 51.83 per cent stake in the company as of March 01, while FII and MF ownerships stood at 22.31 per cent and 7.5 per cent, respectively.

Key Financials
With a market capitalisation of Rs 27117.24 crore, the company operates in the Pharma - Indian industry. For the quarter ended 31-Dec-2022, the company reported consolidated sales of Rs 6499.78 crore, up 12.13 per cent from the previous quarter?s Rs 5796.56 crore and up 7.13 per cent from the same quarter a year ago. The company reported net profit of Rs 491.26 crore for the latest quarter, down 18.76 per cent from the corresponding quarter last year.

Technical Indicators
The relative strength index (RSI) of the stock stands at 55.41. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold condition when it is below 30. Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.